The risk of cerebral venous thrombosis (CVT) from Covid-19 is 8 times higher compared to AstraZeneca’s vaccine and 10 times higher compared to mRNA vaccines.

Singapore ranks second globally for having the best IP protection, according to the World Economic Forum’s Global Competitiveness Report 2019.